^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
CD30 biAb-AATC
i
Other names: CD30 biAb-AATC, anti-CD30 Bispecific Antibody-armed anti-CD3-Activated Autologous T-cells
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Medical College of Wisconsin, Tundra Targeted Therap
Drug class:
CD3 agonist, T-cell stimulant, CD30 inhibitor
Related drugs:
2years
CD30biAb-AATC for CD30+ Malignancies (clinicaltrials.gov)
P1/2, N=42, Not yet recruiting, Medical College of Wisconsin
New P1/2 trial
|
TNFRSF8 (TNF Receptor Superfamily Member 8) • CSF2 (Colony stimulating factor 2)
|
TNFRSF8 expression
|
CD30 biAb-AATC
Share via
